Illumina, Inc announced the Genome AnalyzerIIe sequencing system, designed to provide a lower-priced entry point into next-generation sequencing. Priced at $250,000 USD, the new system leverages the architecture of Illumina's widely-adopted Genome AnalyzerIIx and its proven sequencing-by-synthesis chemistry to generate approximately 200 million paired-end reads and 20 gigabases (Gb) of data per run at launch. As Illumina introduces advances to increase the output of the Genome AnalyzerIIx to 95 Gb, the output of the Genome AnalyzerIIe is expected to reach 40 Gb and 300 million paired-end reads per run. The system's compelling price point coupled with its ease of use and proven sequencing technology ideally positions it for smaller laboratories interested in next-generation sequencing.

"With the addition of the Genome AnalyzerIIe, Illumina now offers the broadest range of sequencing instruments in the industry," said Jay Flatley, president and CEO of Illumina. "The Genome AnalyzerIIe is a particularly important addition to our portfolio as it will allow a wide range of labs and institutions with limited capital budgets to affordably add next-generation sequencing capabilities."

Illumina provides an extensive portfolio of sequencing instruments designed to meet a wide range of user and application requirements --

Genome AnalyzerIIe - For researchers with limited capital budgets, the Genome AnalyzerIIe provides an affordable entry point into next-generation sequencing. At launch, the Genome AnalyzerIIe provides 20 Gb of output and 200 million paired-end reads along with the industry's simplest workflow and system operation.

Genome AnalyzerIIx - The most widely adopted next-generation sequencing platform in the industry, the Genome AnalyzerIIx is ideally suited for researchers with medium to high output requirements. Currently generating in excess of 50 Gb of data per run, the Genome AnalyzerIIx is a proven and scalable platform offering application flexibility, ease of use, and low operating cost.

HiSeq 2000 - Redefining the trajectory of sequencing, HiSeq 2000 offers the best solution for applications demanding the highest throughput and lowest operating costs. With up to 200 Gb of output and two billion paired-end reads, HiSeq provides unprecedented sequencing output and user experience.

iScanSQ - Capable of providing up to 20 Gb of output and 200 million paired-end reads, iScanSQ offers researchers the flexibility to access both sequencing and microarray processing on a single platform. It is expected to launch in Q2 2010.

The Genome AnalyzerIIe is expected to begin shipping in Q1 2010.

Illumina is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.